Hyperfine (HYPR) Cash & Current Investments (2020 - 2026)
Hyperfine's (HYPR) quarterly Cash & Current Investments came in at $41.3 million in Q1 2026, up 23.09% YoY from $33.5 million in Q1 2025, and up 14.53% on a QoQ basis from $36.0 million in Q4 2025.
Hyperfine (HYPR) Cash & Current Investments (2020 - 2026) Analysis & Trends
Hyperfine (HYPR) has 7 years of Cash & Current Investments data on file, last reported at $41.3 million in Q1 2026.
- Quarterly Cash & Current Investments rose 23.09% year-over-year to $41.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.3 million (up 23.09% YoY) and the FY2025 annual result came in at $36.0 million, down 4.33% from the prior year.
- Cash & Current Investments grew to $41.3 million in Q1 2026, from $36.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $163.6 million in Q1 2022 to a low of $22.0 million in Q3 2025.
- A 5-year average of $75.5 million and a median of $63.2 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 104.26% — and 2025, when it slumped 52.47%.
- Tracing HYPR's Cash & Current Investments over 5 years: stood at $118.2 million in 2022, then plunged by 35.89% to $75.8 million in 2023, then slumped by 50.3% to $37.7 million in 2024, then decreased by 4.33% to $36.0 million in 2025, then advanced by 14.53% to $41.3 million in 2026.
- The last three Cash & Current Investments figures came in at $41.3 million (Q1 2026), $36.0 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | 44.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.76 Mn |
| Mar 31, 2026 | 41.28 Mn |
| Dec 31, 2025 | 36.04 Mn |
| Sep 30, 2025 | 22.03 Mn |
| Jun 30, 2025 | 25.58 Mn |
| Mar 31, 2025 | 33.53 Mn |
| Dec 31, 2024 | 37.67 Mn |
| Sep 30, 2024 | 45.98 Mn |
| Jun 30, 2024 | 53.81 Mn |
| Mar 31, 2024 | 63.20 Mn |
| Dec 31, 2023 | 75.80 Mn |
| Sep 30, 2023 | 85.97 Mn |
| Jun 30, 2023 | 94.92 Mn |
| Mar 31, 2023 | 104.74 Mn |
| Dec 31, 2022 | 118.24 Mn |
| Sep 30, 2022 | 133.74 Mn |
| Jun 30, 2022 | 146.71 Mn |
| Mar 31, 2022 | 163.56 Mn |
| Dec 31, 2021 | 191.16 Mn |
| Sep 30, 2021 | 65.48 Mn |